Joji Suzuki, MD
Dr Joji Suzuki is a faculty within the Division of Addiction Treatment and Prevention, Psychiatry Department, Mass General Brigham, Brigham and Women’s Hospital (BWH), and an Associate Professor of Psychiatry at Harvard Medical School. He completed his medical training at Boston University School of Medicine, general psychiatry residency at Maine Medical Center, and addiction psychiatry fellowship at Boston Medical Center. He is board certified in Psychiatry, Addiction Psychiatry and Addiction Medicine. He has successfully launched numerous treatment programs over the course of his career, including the comprehensive outpatient dual diagnosis addiction clinic at Brigham and Women’s Faulkner Hospital, and the low-barrier, low-threshold, harm-reduction Dushku Palandjian Bridge Clinic at BWH. He is now a principal investigator on multiple NIH-funded clinical trials to evaluate treatments for substance use disorders, including the use of GLP-1 receptor agonists and psychedelic therapies.

Stephanie Weiss, MD, PhD
Dr. Stephanie Weiss is the Staff Research Physician serving the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011. She is board certified in addiction medicine and medical toxicology and participated in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA. Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the NIDA IRP mission of conducting inpatient and outpatient proof-of-concept human laboratory therapeutic and imaging studies for addictive disorders. Her research interests include GLP-1RAs, medication misuse, and improving interpretation of urine drug testing.

James Whitledge, MD
Dr. Jim Whitledge graduated from Tufts University School of Medicine, and subsequently completed a residency in emergency medicine at Beth Israel Deaconess Medical Center and fellowship training at the Harvard Medical Toxicology Fellowship. He is currently an emergency physician and medical toxicologist practicing within the University of Vermont Health Network. He enjoys taking call for the Northern New England Poison Center, and is also a consultant toxicologist for the Nepal Poison Information Center. Jim has a particular interest in drug and antidotal shortages, novel treatments for antimuscarinic delirium, pediatric toxicology, and treatment of substance use disorders. Jim spends his free time skiing, biking, and hiking with his family, and is excited when he finds mushrooms and owls in the woods.

Charles McKay, MD, FACMT
Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and drug-induced impairment.

Neil deGrasse Tyson, PhD
Neil deGrasse Tyson, world-renowned astrophysicist and science communicator, is the fifth head of the Hayden Planetarium at the American Museum of Natural History and a research associate in its Department of Astrophysics. Educated at Harvard and Columbia, he has advised NASA and U.S. presidential commissions, authored over a dozen bestselling books including Astrophysics for People in a Hurry, and hosted acclaimed programs such as NOVA ScienceNOW, StarTalk, and Cosmos: A Spacetime Odyssey and Cosmos: Possible Worlds. Recipient of NASA’s Distinguished Public Service Medal and more than twenty honorary doctorates, Tyson has made it his life’s work to bring the wonders of the universe to audiences worldwide.

Scott Hamilton Kennedy
Scott Hamilton Kennedy is an Academy Award® nominee and a multifaceted filmmaker, known for his impactful documentaries that often delve into pressing social issues. As the founder of Black Valley Films, he has created critically acclaimed works such as “The Garden” and “Food Evolution,” showcasing his commitment to science and truth in storytelling. His latest project, “Shot In The Arm,” addresses the intersection of health crises and misinformation, further establishing him as a vital voice in contemporary documentary filmmaking.

EAPCCT | EPITOX | Ophir Lavon, MD
Dr. Ophir Lavon is a board-certified medical toxicologist, clinical pharmacologist, and internal medicine specialist. He is the director of the Clinical Pharmacology and Toxicology Unit at Carmel Medical Center (Haifa, Israel), and leads its fellowship program. Dr. Lavon is a board member of the European Association of Poison Centres and Clinical Toxicologists (EAPCCT) and serves as the chairperson of its Communication Committee. He is an active member of ACMT and AACT. Dr. Lavon is a senior lecturer at the Rappaport Faculty of Medicine of the Technion – Israel Institution of Technology, Haifa, Israel. Dr. Lavon is the former director of the Patient Safety and Risk Management Unit at Carmel Medical Center

MENATOX | Bruno Mégarbane, MD, PhD
Bruno Mégarbane is Professor of critical care medicine at Paris University and directs a research team at INSERM UMRS-1144. He is the Head of the Department of Medical and Toxicological Critical Care at Lariboisière Hospital, Paris, France. He conducted several clinical and experimental studies in clinical toxicology.

APAMT | Thanjira Jiranantakan, MD, MPH, FACOEM, FAFPHM, FAFOEM
Dr. Thanjira Jiranantakan is specialized in public health, medical toxicology, internal medicine, addiction medicine, and occupational and environmental medicine. She has practiced in the US, Australia, and Thailand and has experience working with the WHO, the US Federal OSHA, government bodies, and NGOs. She is a senior staff specialist and researcher at Royal Prince Alfred Hospital, a Senior Clinical Lecturer at the University of Sydney, and a Medical Toxicologist and Public Health Advisor at the NSW Ministry of Health, Australia. She is the President-Elect for the Asia Pacific Association of Medical Toxicology (APAMT). She has integrated practice in clinical service, policy and research.

TAPNA | Geoffrey Isbister, MD
Geoffrey Isbister, MD is Director of Clinical Toxicology at Calvary Mater Newcastle, Professor at the University of Sydney, and a consultant toxicologist to the NSW Poisons Information Centre. He was appointed a Member of the Order of Australia in 2019 for his contributions to toxicology. Dr. Isbister serves as President of the Asia Pacific Association of Medical Toxicologists and as a Board Member of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). An internationally recognized expert in snakebite envenomation, he has authored over 390 peer-reviewed publications, secured more than $20 million in research funding, and led numerous randomized controlled trials and large cohort studies.

Timothy B. Erickson, MD, FACEP, FACMT, FAACT
Dr. Erickson is an emergency medicine physician at Mass General Brigham in Boston, MA. He is the Division Chief of Medical Toxicology in the Department of Emergency Medicine. He is a Full Professor at Harvard Medical School and the Harvard Humanitarian Initiative (HHI). He is a Professor Emeritus at the University of Illinois where he established the UIC Center for Global Health. His areas of expertise include CBRNE response and training, environmental toxicology, crisis in climate change, wastewater epidemiology, and acute injuries from global conflict settings such as Ukraine, Syria, Kosovo, Sudan, and Rwanda. Over the past 3 decades he had conducted numerous projects and deployments to Ukraine with NATO and International Medical Corps (IMC).